查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596492

智慧藥物和藥丸市場：按目標領域、類型、最終用戶、應用 - 2025-2030 年全球預測

Smart Drugs & Pills Market by Target Area (Esophagus, Large Intestine, Small Intestine), Type (Over-the-Counter Nootropics, Prescription Nootropics), End User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年智慧藥品市場價值為82.8億美元，預計到2024年將達到101.8億美元，複合年成長率為24.18%，預計到2030年將達到377.1億美元。

智慧藥物或錠劑，通常稱為精神藥物或認知增強劑，是旨在改善健康人的認知功能、記憶力、創造力和動機的物質。隨著人們對增強智力和延長壽命的興趣日益濃厚，市場範圍擴大到包括藥品、營養食品和機能性食品。這項需求源自於職業環境中認知需求的增加以及阿茲海默症和過動症等認知障礙盛行率的上升。應用範圍廣泛，涵蓋醫療保健、學術、軍事和企業部門，這些領域的認知增強受到高度重視。最終用途的範圍在尋求頭腦清晰和提高生活品質的學生、專業人士和老年人中尤其廣泛。

主要市場統計
基準年[2023] 82.8億美元
預測年份 [2024] 101.8億美元
預測年份 [2030] 377.1億美元
複合年成長率（%） 24.18%

市場成長受到生物技術進步、尋求認知支持的老齡化人口增加以及心理健康意識增強等因素的影響。提供輕鬆取得智慧型藥物的數位平台的興起也推動了市場擴張。個人化醫療的發展存在重大機遇，它將人工智慧和機器學習相結合，根據個人需求量身定做認知增強解決方案。然而，市場成長受到監管監督、有關這些藥物的濫用和長期安全性的道德爭論以及消費者對功效和天然替代品不同看法的挑戰。

創新機會在於增強藥物輸送系統，例如智慧藥丸，透過感測器和無線連接來監測藥物療效和患者健康。科技和製藥公司之間的合作可以推動精準醫療和資料分析的突破，從而改善使用者的治療結果。儘管存在固有的挑戰，但消費者對改善認知功能的需求持續成長，智慧藥物市場也有望顯著成長。鼓勵公司投資於透明和道德的行銷和研究，以增加消費者的信任並與監管環境保持一致，並且正在實施智慧藥物以在多方面的市場環境中增強認知能力，這是一種可能的選擇。

市場動態：揭示快速發展的智慧藥品和藥丸市場的關鍵市場洞察

供需的動態交互作用正在改變智慧藥品和藥丸市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 老年人口增加，慢性病盛行率上升
    • 增加患者對微創手術的偏好以實現更好的診斷
    • 增強認知功能的智慧藥物和藥丸越來越受歡迎
  • 市場限制因素
    • 與智慧藥物相關的高成本
  • 市場機會
    • 智慧藥品的持續技術進步與創新
    • 加大智慧藥品研發投入
  • 市場挑戰
    • 與智慧藥物和藥丸相關的副作用

波特五力：駕馭智慧藥品和藥丸市場的策略工具

波特的五力架構是了解智慧藥物和藥丸市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解智慧藥品和藥丸市場的外部影響

外部宏觀環境因素在塑造智慧藥物和藥丸市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解智慧藥品和藥丸市場的競爭格局

智慧藥物和藥丸市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 智慧藥品和藥丸市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估智慧藥品和藥丸市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了智慧藥品和藥丸市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對智慧藥物和藥丸市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化加劇和慢性病盛行率上升
      • 越來越多的患者選擇微創手術以獲得更好的診斷
      • 改善認知功能的智慧藥物和藥丸越來越受歡迎
    • 抑制因素
      • 與智慧藥物相關的高成本
    • 機會
      • 智慧藥品的持續技術進步與創新
      • 加大研發投入 開發智慧藥品和藥丸
    • 任務
      • 與智慧藥物和藥丸相關的副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按目標區域分類的智慧藥品和藥丸市場

  • 食道
  • 冒號
  • 小腸
  • 胃

第7章智慧藥物和藥丸市場：按類型

  • 非處方促智藥
    • 咖啡因
    • 肌酸
    • L-茶氨酸
    • Omega-3脂肪酸
    • 消旋體
  • 無需處方箋的促智藥

第8章智慧藥品和藥丸市場：依最終用戶分類

  • 診斷中心
  • 醫院
  • 調查機構

第9章智慧藥品與藥丸市場：依應用分類

  • 膠囊內視鏡
  • 藥物輸送
  • 病患監測

第10章美洲的智慧藥品和藥丸市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太智慧藥品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的智慧藥品和藥丸市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • BD 和 BIOCORP 簽署協議，實現自我管理注射藥物的連接和可追溯性
    • AARDEX 集團將 etectRx 添加到 MEMS 黏合硬體生態系統
    • Hamilton Beach Brands 和 Health Beacon 宣佈在美國推出 Smart Sharp Corporation Bin(TM) 注射護理管理系統
    • AdhereTech 宣布與 AARDEX 集團合作，透過智慧藥瓶、軟體和資料分析提高用藥依從性
    • Olympus遷至漢堡新總部 - 奧林巴斯歐洲、中東和非洲地區
    • 智慧藥丸Start-UpsetectRx 與 Pear Therapeutics 合作
    • “CapsoVision Inc. 宣布 FDA 對 COVID-19 大流行期間在家進行膠囊內視鏡檢查 CapsoCam Plus 的執法自由裁量權”
  • 戰略分析和建議

公司名單

  • Aardex Group
  • AnX Robotica Corp.
  • CapsoVision, Inc.
  • Check-Cap Ltd.
  • GE Healthcare
  • IntroMedic Co., Ltd.
  • Jinshan Science & Technology（Group）Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Novartis AG
  • Olympus Corporation
  • RF Co., Ltd.
Product Code: MRR-43676CF42B9A

The Smart Drugs & Pills Market was valued at USD 8.28 billion in 2023, expected to reach USD 10.18 billion in 2024, and is projected to grow at a CAGR of 24.18%, to USD 37.71 billion by 2030.

Smart drugs and pills, often known as nootropics or cognitive enhancers, are substances designed to improve cognitive function, memory, creativity, or motivation in healthy individuals. With growing interest in enhancing mental performance and promoting longevity, the market scope has expanded to include pharmaceuticals, nutraceuticals, and functional foods. Their necessity stems from increasing cognitive demands in professional settings and the rising prevalence of cognitive impairments such as Alzheimer's and ADHD. Applications are widespread, spanning healthcare, academic, military, and corporate sectors where cognitive enhancement is highly valued. The end-use scope is particularly strong among students, professionals, and elderly populations seeking mental acuity and improved quality of life.

KEY MARKET STATISTICS
Base Year [2023] USD 8.28 billion
Estimated Year [2024] USD 10.18 billion
Forecast Year [2030] USD 37.71 billion
CAGR (%) 24.18%

Market growth is influenced by factors such as advancements in biotechnology, a growing aging population seeking cognitive support, and heightened awareness about mental health and wellness. The rise of digital platforms offering easy access to smart drugs also fuels market expansion. Notable opportunities exist in the development of personalized medicine, integrating AI and machine learning to tailor cognitive enhancement solutions to individual needs. However, market growth is challenged by regulatory scrutiny, ethical debates about the misuse and long-term safety of such drugs, and variable consumer perceptions regarding efficacy and natural alternatives.

Innovation opportunities lie in enhancing drug delivery systems like smart pills with sensors and wireless connectivity to monitor drug efficacy and patient health. Collaborations between technology companies and pharmaceutical firms can spur breakthroughs in precision medicine and data analytics to enhance user outcomes. Despite the inherent challenges, the smart drug market is poised for considerable growth as consumer demand for cognitive improvement continues to rise. Companies are recommended to invest in transparent, ethical marketing and research to align with regulatory standards while amplifying consumer trust, making smart drugs a viable option for cognitive enhancement in a multifaceted market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Drugs & Pills Market

The Smart Drugs & Pills Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population coupled with rising prevalence of chronic disorders
    • Increased patient preference for minimally invasive surgeries for better diagnosis
    • Rising popularity of smart drugs & pills to enhance cognitive functions
  • Market Restraints
    • High cost associated with smart drugs & pills
  • Market Opportunities
    • Ongoing technological advancements and innovations in smart drugs & pills
    • Increasing research and development investment in developing smart drugs & pills
  • Market Challenges
    • Adverse reactions associated with smart drugs & pills

Porter's Five Forces: A Strategic Tool for Navigating the Smart Drugs & Pills Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Drugs & Pills Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Drugs & Pills Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Drugs & Pills Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Drugs & Pills Market

A detailed market share analysis in the Smart Drugs & Pills Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Drugs & Pills Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Drugs & Pills Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Smart Drugs & Pills Market

A strategic analysis of the Smart Drugs & Pills Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Smart Drugs & Pills Market, highlighting leading vendors and their innovative profiles. These include Aardex Group, AnX Robotica Corp., CapsoVision, Inc., Check-Cap Ltd., GE Healthcare, IntroMedic Co., Ltd., Jinshan Science & Technology (Group) Co., Ltd., Koninklijke Philips NV, Medtronic PLC, Novartis AG, Olympus Corporation, and RF Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Smart Drugs & Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Target Area, market is studied across Esophagus, Large Intestine, Small Intestine, and Stomach.
  • Based on Type, market is studied across Over-the-Counter Nootropics and Prescription Nootropics. The Over-the-Counter Nootropics is further studied across Caffeine, Creatine, L-theanine, Omega-3 fatty acids, and Racetams.
  • Based on End User, market is studied across Diagnostic Centers, Hospitals, and Research Institutes.
  • Based on Application, market is studied across Capsule Endoscopy, Drug Delivery, and Patient Monitoring.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population coupled with rising prevalence of chronic disorders
      • 5.1.1.2. Increased patient preference for minimally invasive surgeries for better diagnosis
      • 5.1.1.3. Rising popularity of smart drugs & pills to enhance cognitive functions
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with smart drugs & pills
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements and innovations in smart drugs & pills
      • 5.1.3.2. Increasing research and development investment in developing smart drugs & pills
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse reactions associated with smart drugs & pills
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Smart Drugs & Pills Market, by Target Area

  • 6.1. Introduction
  • 6.2. Esophagus
  • 6.3. Large Intestine
  • 6.4. Small Intestine
  • 6.5. Stomach

7. Smart Drugs & Pills Market, by Type

  • 7.1. Introduction
  • 7.2. Over-the-Counter Nootropics
    • 7.2.1. Caffeine
    • 7.2.2. Creatine
    • 7.2.3. L-theanine
    • 7.2.4. Omega-3 fatty acids
    • 7.2.5. Racetams
  • 7.3. Prescription Nootropics

8. Smart Drugs & Pills Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals
  • 8.4. Research Institutes

9. Smart Drugs & Pills Market, by Application

  • 9.1. Introduction
  • 9.2. Capsule Endoscopy
  • 9.3. Drug Delivery
  • 9.4. Patient Monitoring

10. Americas Smart Drugs & Pills Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Smart Drugs & Pills Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Smart Drugs & Pills Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs
    • 13.3.2. AARDEX Group adds etectRx to their MEMS Adherence Hardware ecosystem
    • 13.3.3. Hamilton Beach Brands, Inc. and HealthBeacon plc Announce the US Launch of the Smart Sharps Bin(TM) Injection Care Management System
    • 13.3.4. AdhereTech Announces Partnership with AARDEX Group to Boost Medication Adherence with Smart Pill Bottle, Software and Data Analytics
    • 13.3.5. Olympus Moves into New Headquarters in Hamburg - Olympus EMEA
    • 13.3.6. Smart pill startup etectRx strikes partnership with Pear Therapeutics
    • 13.3.7. "CapsoVision Inc. Announces FDA Enforcement Discretion for At-Home Capsule Endoscopy Administration of CapsoCam Plus during COVID-19"
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aardex Group
  • 2. AnX Robotica Corp.
  • 3. CapsoVision, Inc.
  • 4. Check-Cap Ltd.
  • 5. GE Healthcare
  • 6. IntroMedic Co., Ltd.
  • 7. Jinshan Science & Technology (Group) Co., Ltd.
  • 8. Koninklijke Philips NV
  • 9. Medtronic PLC
  • 10. Novartis AG
  • 11. Olympus Corporation
  • 12. RF Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. SMART DRUGS & PILLS MARKET RESEARCH PROCESS
  • FIGURE 2. SMART DRUGS & PILLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMART DRUGS & PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SMART DRUGS & PILLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMART DRUGS & PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMART DRUGS & PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SMART DRUGS & PILLS MARKET DYNAMICS
  • TABLE 7. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CAFFEINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CREATINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY L-THEANINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY RACETAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY PRESCRIPTION NOOTROPICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. SMART DRUGS & PILLS MARKET, FPNV POSITIONING MATRIX, 2023